This inventor holds 0 USPTO granted patents, plus 8 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Jan Bergman: Innovator in Pharmaceutical Formulations
Introduction
Jan Bergman is a notable inventor based in Sweden. He has made significant contributions to the field of pharmaceutical formulations. His work primarily focuses on developing compositions that target viral infections.
Latest Patents
Jan Bergman holds a patent for a pharmaceutical formulation for topical administration comprising B220. This composition is designed for the treatment of herpes virus infections of the skin or mucous membranes in mammals. Additionally, he has developed methanethione compounds that exhibit antiviral activity, particularly for treating influenza.
Career Highlights
Throughout his career, Jan has worked with several companies, including Vironova Thionation AB and Vironova Herpes AB. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
Jan has collaborated with notable coworkers such as Birgitta Pettersson and Vedran Hasimbegovic. Their combined efforts have contributed to advancements in antiviral treatments.
Conclusion
Jan Bergman is a dedicated inventor whose work in pharmaceutical formulations has the potential to impact the treatment of viral infections significantly. His innovative contributions continue to shape the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile